Combinations of novel peptides and peptides for use in immunotherapy for chronic lymphocytic leukemia and other cancers

摘要

The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to immunotherapy of cancer. The present invention also relates to the use of tumor-associated T cells for the promotion of antitumor immune responses or for the transfer of cells to patients by in vitro stimulation, alone or in combination with other tumor-associated peptides that can serve as active pharmaceutical ingredients of, for example, Epi top. / RTI Peptides bound to molecules of the main histocompatibility complex (MHC). Such peptides may also be targets of antibodies, soluble T cell receptors and other binding molecules.